Emcure halves price of its semaglutide weight loss drug Poviztra after Novo Nordisk patent expiry — check new rates
Emcure Pharmaceuticals on Thursday announced that it has halved the price of its weight management drug Poviztra, a…
Natco beats rivals with Rs 1,290 semaglutide launch as Novo Nordisk patent expires
Hyderabad-based drug maker Natco Pharma is launching semaglutide injection in the form of multidose vials on Saturday –…
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide,…